Regulatory News for Rare Disease Products-Hot Stocks: BLUE,ICPT,SRPT …Updates
Update-2 uniQure up on deal with BMY (CURE) Cardiovascular Deal with Bristol Myers (BMY) The closing of the uniQure deal with Bristol Myers triggered a $50M payment. Three collaboration targets in cardiovascular and future areas. The stock is up 81% YTD but off its high of $35.50. Update-1 See...
Rayno Life Science Stocks Move Higher: CLVS, RHHBY-ASCO Preview
Rayno Biopharmaceutical Stocks- ASCO Plays or Not Large Caps Rule Clovis Oncology (CLVS) up 16.7%, 79% YTD to $100 level! Several data CLVS Presentations for ASCO including two oral and six posters for non-small cell lung cancer and ovarian cancer. Also with a valuation of only $3.4B and three...
Hot Biotech Sector: Mid-Caps Have Both M&A and Pipeline Premiums
Valuations Step-Up With More Deals Prior to the acquisition of Pharmacyclics (PCYC) by Abbvie (ABBV) for $20B, the top price paid for an emerging biotech company was in the $10B range. Two additional companies among the mid-caps were acquired in prior years: Cubist by Merck in December 2014...
Biotechs Tag Along With Broad Market Rally: FBT Up 3%
Jobs Report Drive Stocks Higher-DOW Up 1.5% Stocks moved higher on the "goldilocks" job report which showed a gain of 223k added in April. The jobs number was too high to raise concerns about an increase in rates but not too bullish because overall productivity is down. Jobless claims are down...
M&A Sparks Biotechs: Alexion Buys Syngeva for $8.4B…Update-1
Orphan Drugs-The Latest Hot Spot in Biotech Large Cap Biotechs Were Red-Specualtive Stocks Were Green XBI 214.9 up 2.36% GEVA $203.4 up 112% NASDAQ 4919 down 0.4% Rare Disease Companies Merge: ALXN and GEVA Alexion Pharmaceuticals (ALXN) the leading company in severe and life threatening...